Regnum Corp. (RGMP)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2022 | 864.67 Thousand USD | -41.93% |
| 2021 | 1.48 Million USD | 32987.09% |
| 2020 | 4500.00 USD | -46.93% |
| 2019 | 8480.00 USD | -82.22% |
| 2018 | 47.69 Thousand USD | 223.36% |
| 2017 | 14.75 Thousand USD | 0.0% |
| 2016 | - USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q3 | - USD | 0.0% |
| 2023 Q1 | 496.08 Thousand USD | -42.63% |
| 2023 Q2 | - USD | -100.0% |
| 2022 Q4 | 864.67 Thousand USD | -17.15% |
| 2022 FY | 864.67 Thousand USD | -41.93% |
| 2022 Q2 | 1.35 Million USD | -3.06% |
| 2022 Q1 | 1.4 Million USD | -5.93% |
| 2022 Q3 | 1.04 Million USD | -23.14% |
| 2021 Q1 | 4500.00 USD | 0.0% |
| 2021 Q4 | 1.48 Million USD | 37122.98% |
| 2021 Q3 | 4000.00 USD | 0.0% |
| 2021 Q2 | 4000.00 USD | -11.11% |
| 2021 FY | 1.48 Million USD | 32987.09% |
| 2020 Q4 | 4500.00 USD | 36.36% |
| 2020 FY | 4500.00 USD | -46.93% |
| 2020 Q3 | 3300.00 USD | -64.43% |
| 2020 Q1 | 1036.00 USD | -87.78% |
| 2020 Q2 | 9278.00 USD | 795.56% |
| 2019 FY | 8480.00 USD | -82.22% |
| 2019 Q1 | 24.08 Thousand USD | -49.5% |
| 2019 Q4 | 8480.00 USD | -41.28% |
| 2019 Q3 | 14.44 Thousand USD | 0.61% |
| 2019 Q2 | 14.35 Thousand USD | -40.41% |
| 2018 Q1 | 16.54 Thousand USD | 12.15% |
| 2018 FY | 47.69 Thousand USD | 223.36% |
| 2018 Q4 | 47.69 Thousand USD | 0.04% |
| 2018 Q3 | 47.67 Thousand USD | 165.95% |
| 2018 Q2 | 17.92 Thousand USD | 8.37% |
| 2017 Q1 | - USD | 0.0% |
| 2017 Q3 | 14.37 Thousand USD | 0.0% |
| 2017 Q4 | 14.75 Thousand USD | 2.61% |
| 2017 FY | 14.75 Thousand USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | 2310.00 USD | -37331.905% |
| Arch Therapeutics, Inc. | 1.95 Million USD | 55.843% |
| Evofem Biosciences, Inc. | 10.55 Million USD | 91.807% |
| Nascent Biotech, Inc. | 552.12 Thousand USD | -56.61% |
| Rebus Holdings, Inc. | 5000.00 USD | -17193.54% |
| Santhera Pharmaceuticals Holding AG | 130.21 Million USD | 99.336% |
| Qrons Inc. | 420.00 USD | -205775.476% |
| Adynxx, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | 770.64 Thousand USD | -12.202% |
| Northwest Biotherapeutics, Inc. | 27.94 Million USD | 96.906% |
| ProtoKinetix, Incorporated | 480.55 Thousand USD | -79.932% |
| Skye Bioscience, Inc. | 11.94 Million USD | 92.758% |
| Eiger BioPharmaceuticals, Inc. | 38.84 Million USD | 97.774% |
| Nanobac Pharmaceuticals, Incorporated | 7.21 Million USD | 88.023% |
| Institute of Biomedical Research Corp. | 76.35 Thousand USD | -1032.458% |
| SQZ Biotechnologies Company | 107.18 Million USD | 99.193% |
| Intellipharmaceutics International Inc. | 1.43 Million USD | 39.619% |
| Propanc Biopharma, Inc. | 72.36 Thousand USD | -1094.883% |
| Mesoblast Limited | 667.9 Million USD | 99.871% |
| Marizyme, Inc. | 22.01 Million USD | 96.072% |
| Genus plc | 1.02 Billion USD | 99.916% |
| VioQuest Pharmaceuticals, Inc. | 1.35 Million USD | 36.344% |
| Pharming Group N.V. | 462.85 Million USD | 99.813% |
| Therapeutic Solutions International, Inc. | 3.31 Million USD | 73.901% |
| CNBX Pharmaceuticals Inc. | 499.03 Thousand USD | -73.268% |
| Nymox Pharmaceutical Corporation | 627 Thousand USD | -37.907% |
| ContraFect Corporation | 20.67 Million USD | 95.819% |
| PsyBio Therapeutics Corp. | 390.36 Thousand USD | -121.504% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 382.17 Thousand USD | -126.25% |
| IMV Inc. | 31.33 Million USD | 97.24% |
| AXIM Biotechnologies, Inc. | 4.14 Million USD | 79.144% |
| MultiCell Technologies, Inc. | 126.22 USD | -684955.459% |
| ONE Bio Corp. | 70.08 Million USD | 98.766% |
| Accustem Sciences Inc. | 939.68 Thousand USD | 7.983% |
| RVL Pharmaceuticals plc | 128.51 Million USD | 99.327% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 431.71 Thousand USD | -100.289% |
| Q BioMed Inc. | 3.51 Million USD | 75.404% |
| Emmaus Life Sciences, Inc. | 35.17 Million USD | 97.542% |
| Mosaic ImmunoEngineering Inc. | 261.27 Thousand USD | -230.943% |
| Biomind Labs Inc. | 73.81 Thousand USD | -1071.347% |
| American Oriental Bioengineering, Inc. | 446.3 Million USD | 99.806% |
| Provectus Biopharmaceuticals, Inc. | 1.44 Million USD | 40.319% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 30.01 Million USD | 97.119% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| THC Farmaceuticals, Inc. | 2.74 Million USD | 68.515% |
| Acro Biomedical Co., Ltd. | 687.48 Thousand USD | -25.774% |
| Curative Biotechnology, Inc. | 2.6 Million USD | 66.784% |
| GB Sciences, Inc. | 103.44 Thousand USD | -735.905% |
| Alpha Cognition Inc. | 2.45 Million USD | 64.738% |
| HST Global, Inc. | 1526.00 USD | -56562.975% |
| CSL Limited | 38.02 Billion USD | 99.998% |
| Wesana Health Holdings Inc. | 987.96 Thousand USD | 12.479% |
| Halberd Corporation | 10.13 Thousand USD | -8434.962% |
| Enzolytics Inc. | 361.7 Million USD | 99.761% |
| Agentix Corp. | 261.39 Thousand USD | -230.797% |
| Resverlogix Corp. | 8.11 Million USD | 89.345% |
| Nuo Therapeutics, Inc. | 1.87 Million USD | 53.955% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 4.54 Billion USD | 99.981% |
| Enzon Pharmaceuticals, Inc. | 47.7 Million USD | 98.187% |
| Endonovo Therapeutics, Inc. | 639.65 Thousand USD | -35.178% |
| RespireRx Pharmaceuticals Inc. | 22.78 Thousand USD | -3695.606% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 8.94 Million USD | 90.338% |
| AVAX Technologies, Inc. | 7.37 Million USD | 88.279% |
| Zenith Capital Corp. | 7410.00 USD | -11569.055% |
| Genscript Biotech Corporation | 3.38 Billion USD | 99.974% |
| Ember Therapeutics, Inc. | 184.00 USD | -469833.152% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 321.8 Thousand USD | -168.695% |
| WPD Pharmaceuticals Inc. | 261.36 Thousand USD | -230.832% |
| Cotinga Pharmaceuticals Inc. | 927.96 Thousand USD | 6.82% |
| Kadimastem Ltd | 2.3 Million USD | 62.472% |
| Helix BioMedix, Inc. | 3.02 Million USD | 71.416% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 52.7 Million USD | 98.359% |
| BioStem Technologies, Inc. | 14.56 Million USD | 94.061% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 57.09 Thousand USD | -1414.48% |
| LadRx Corporation | 2.3 Million USD | 62.534% |
| Cell Source, Inc. | 195.17 Thousand USD | -343.036% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -144.524% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -144.524% |
| NovAccess Global Inc. | 62.24 Thousand USD | -1289.084% |
| Affymax, Inc. | 7.44 Million USD | 88.383% |
| Itoco Inc. | 1.4 Million USD | 38.241% |
| Rasna Therapeutics, Inc. | 95.65 Thousand USD | -803.935% |
| Pathfinder Cell Therapy, Inc. | 106 Thousand USD | -715.733% |
| Mobile Lads Corp. | 52.00 USD | -1662740.385% |
| CytoDyn Inc. | 11.13 Million USD | 92.235% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 142.97 Thousand USD | -504.788% |
| NanoSphere Health Sciences Inc. | 17.88 Thousand USD | -4736.001% |
| Alseres Pharmaceuticals, Inc. | 385.47 Thousand USD | -124.317% |
| SYBLEU INC | 330.46 Thousand USD | -161.652% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 409.42 Thousand USD | -111.195% |
| International Stem Cell Corporation | 5.39 Million USD | 83.958% |
| Bioxytran, Inc. | 137.63 Thousand USD | -528.225% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 15 Million USD | 94.236% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 16.57 Million USD | 94.785% |
| Adhera Therapeutics, Inc. | 79 Thousand USD | -994.528% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | 7.51 Million USD | 88.497% |
| Neutra Corp. | 2851.00 USD | -30228.902% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | 97.332% |
| PureTech Health plc | 693.97 Million USD | 99.875% |
| Coeptis Therapeutics, Inc. | 8.07 Million USD | 89.287% |
| IXICO plc | 15.84 Million USD | 94.543% |
| IntelGenx Technologies Corp. | 8.28 Million USD | 89.56% |
| Gelesis Holdings, Inc. | 103.32 Million USD | 99.163% |
| CSL Limited | 38.02 Billion USD | 99.998% |
| Cellectis S.A. | 333.99 Million USD | 99.741% |